Back to News
Market Impact: 0.1

Elite Pharmaceuticals, Inc. Elects Aqeel A. Fatmi and John W. LaRocca to Board of Directors on October 28, 2026

Source: Nasdaq

Management & Governance

On October 28, 2026, Elite Pharmaceuticals’ board unanimously elected Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq., as Class II and Class I directors, respectively. The board expanded from four to six directors; the article text is truncated before stating when the appointments take effect.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

More News

From AllMind Research

Browse all research